A significant portion of the population, around a quarter, is at risk of heart attacks and strokes due to a specific type of cholesterol that standard statin medications cannot effectively treat. Researchers are now exploring new treatments for this condition, with emerging drugs from pharmaceutical companies Lilly and Amgen showing promise in addressing this previously untreatable form of high cholesterol.
Source: https://www.barrons.com/articles/heart-disease-cholesterol-eli-lilly-amgen-drugs-f283b272